These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7972978)

  • 1. Influence of lung function and postnatal age on the response to nebulized ipratropium bromide in children born prematurely.
    Yüksel B; Greenough A
    Respir Med; 1994 Aug; 88(7):527-30. PubMed ID: 7972978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ipratropium bromide and airways function in wheezy infants.
    Prendiville A; Green S; Silverman M
    Arch Dis Child; 1987 Apr; 62(4):397-400. PubMed ID: 2954510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical response to nebulized ipratropium bromide in pre-term infants asymptomatic at follow-up.
    Yuksel B; Greenough A; Green S
    Respir Med; 1991 May; 85(3):189-94. PubMed ID: 1831916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable response to bronchodilator therapy in young children born prematurely.
    Yuksel B; Greenough A
    Respir Med; 1993 Jul; 87(5):359-64. PubMed ID: 8209055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchodilator effect of nebulized sodium cromoglycate in children born prematurely.
    Yuksel B; Greenough A
    Eur Respir J; 1993 Mar; 6(3):387-90. PubMed ID: 8472830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
    Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
    Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplifying the assessment of patients with chronic airflow limitation for home nebulizer therapy.
    Goldman JM; Teale C; Muers MF
    Respir Med; 1992 Jan; 86(1):33-8. PubMed ID: 1533047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the bronchodilator efficacy of nebulized pirenzepine and ipratropium bromide in patients with airway obstructive lung disease.
    Ceyhan B; Celikel T; Simsir S; Kandemir B
    Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):510-3. PubMed ID: 8262690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plethysmograph and interrupter resistance measurements in prematurely born young children.
    Thomas MR; Rafferty GF; Blowes R; Peacock JL; Marlow N; Calvert S; Milner A; Greenough A
    Arch Dis Child Fetal Neonatal Ed; 2006 May; 91(3):F193-6. PubMed ID: 16239293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airways resistance and lung volume before and after bronchodilator therapy in symptomatic preterm infants.
    Yuksel B; Greenough A
    Respir Med; 1994 Apr; 88(4):281-6. PubMed ID: 8036290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease.
    Wilkie RA; Bryan MH
    J Pediatr; 1987 Aug; 111(2):278-82. PubMed ID: 2956405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects on lung function of two methods of bronchodilator administration.
    Yuksel B; Greenough A
    Respir Med; 1994 Mar; 88(3):229-33. PubMed ID: 8209072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
    Ikeda A; Nishimura K; Koyama H; Izumi T
    Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is nebulized ipratropium bromide effective in the treatment of exacerbations of chronic obstructive pulmonary disease?].
    Musil J
    Vnitr Lek; 2000 Jan; 46(1):45-8. PubMed ID: 10953664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease.
    Dunst MN
    Am Rev Respir Dis; 1989 Oct; 140(4):1174. PubMed ID: 2529802
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose of nebulized ipratropium bromide in acute severe asthma.
    Whyte KF; Gould GA; Jeffrey AA; Airlie MA; Flenley DC; Douglas NJ
    Respir Med; 1991 Nov; 85(6):517-20. PubMed ID: 1837931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.
    Colice GL
    Am J Med; 1996 Jan; 100(1A):11S-18S. PubMed ID: 8610712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of ipratropium bromide as a nebulized solution on respiratory function in mechanically ventilated patients].
    Yang SC; Lee TS; Chen GC
    J Formos Med Assoc; 1993 Mar; 92 Suppl 1():S19-24. PubMed ID: 8103382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of early administration of nebulized ipratropium bromide in children with asthmatic crisis].
    Benito Fernández J; Mintegui Raso S; Sánchez Echaniz J; Vázquez Ronco MA; Pijoan Zubizarreta JI
    An Esp Pediatr; 2000 Sep; 53(3):217-22. PubMed ID: 11083963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.